Two UK coronavirus stocks I’d buy in August

While Covid-19 has smashed some industries, it has created opportunities for others. Here are two coronavirus stocks I think look well placed for growth.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

While the coronavirus has devastated some industries, it has created enormous opportunities for others. Many companies in the technology and healthcare sectors, for example, have seen much higher demand for their services in the wake of the pandemic.

In this article, I’m going to highlight two UK companies that are helping the world deal with the Covid-19 pandemic. I think these ‘coronavirus stocks’ have significant growth potential.

This company is leading the fight against Covid-19 

One UK company that is certainly helping the world fight Covid-19 is Reckitt Benckiser (LSE: RB). It’s a leading health and hygiene company that owns a number of well-known, trusted disinfectant brands such as Dettol and Lysol.

Reckitt’s sales are literally flying right now. For the first half of the year, sales in its Hygiene division were up 16.1% on a like-for-like basis. Meanwhile, total group revenue for the period was up 11.9%.

Going forward, I expect sales growth to remain robust as I believe there will be an increased focus on hygiene globally. As the company said recently: “Covid-19 is likely to be with us for the foreseeable future and, as a society, we are embedding new hygiene practices to protect our way of life.”

What I find particularly interesting is that professional opportunities are opening up with service providers such as hotels and airlines. These companies are looking to provide consumers with the highest standards of hygiene. Recently, Reckitt has created a new professional service and signed agreements with the likes of Hilton, Avis, and Delta Airlines to help keep their customers safe and protected.

This coronavirus stock isn’t the cheapest stock around. Currently, RB shares trade on a forward-looking P/E ratio of about 24. I wouldn’t let that valuation put you off though. This is a high-quality company and the trend appears to be up. Barclays has it at a price target of 9,000p. That’s well above the current share price.

An under-the-radar coronavirus stock 

Another UK coronavirus stock that I like the look of right now is Computacenter (LSE: CCC). It’s a leading FTSE 250 technology company that advises organisations on IT strategy, implements technology solutions, and manages its customers’ IT infrastructures.

Computercenter appears to have a lot of momentum right now. Just last week, the company advised that due to the work-from-home trend, it had seen a “surge” in demand for IT equipment. The company also advised that its adjusted profit before tax in the first half of 2020 has turned out to be “substantially ahead” of the same period last year. It believes that 2020 will be a year of “material” progress, following a “record-breaking” 2019. 

I tipped this under-the-radar technology stock as a ‘buy’ during the stock market crash in March when it was trading at around 1,060p. Today, the coronavirus stock trades near 2,000p. I still see a lot of value here though. CCC’s forward-looking P/E ratio is about 21. I think that is very reasonable given the company’s track record and growth prospects in a post-Covid-19 world.

Edward Sheldon owns shares in Reckitt Benckiser. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Close-up of British bank notes
Investing Articles

£20,000 for a Stocks and Shares ISA? Here’s how to try and turn it into a monthly passive income of £493

Hundreds of pounds in passive income a month from a £20k Stocks and Shares ISA? Here's how that might work…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

£5,000 put into Nvidia stock last Christmas is already worth this much!

A year ago, Nvidia stock was already riding high -- but it's gained value since. Our writer explores why and…

Read more »

Investing Articles

Are Tesco shares easy money heading into 2026?

The supermarket industry is known for low margins and intense competition. But analysts are bullish on Tesco shares – and…

Read more »

Smiling black woman showing e-ticket on smartphone to white male attendant at airport
Investing Articles

Can this airline stock beat the FTSE 100 again in 2026?

After outperforming the FTSE 100 in 2025, International Consolidated Airlines Group has a promising plan to make its business more…

Read more »

Investing Articles

1 Stocks and Shares ISA mistake that will make me a better investor in 2026

All investors make mistakes. The best ones learn from them. That’s Stephen Wright’s plan to maximise returns from his Stocks…

Read more »

Portrait Of Senior Couple Climbing Hill On Hike Through Countryside In Lake District UK Together
Investing Articles

I asked ChatGPT if £20,000 would work harder in an ISA or SIPP in 2026 and it said…

Investors have two tax-efficient ways to build wealth, either in a Stocks and Shares ISA or SIPP. Harvey Jones asked…

Read more »

Investing Articles

How much would I need invested in an ISA to earn £2,417 a month in passive income?

This writer runs the numbers to see what it takes in an ISA to reach £2,417 a month in passive…

Read more »

Investing Articles

Rolls-Royce shares or Melrose Industries: Which one is better value for 2026?

Rolls-Royce shares surged in 2025, surpassing most expectations. Dr James Fox considers whether it offers better value than peer Melrose.

Read more »